Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subretinal Macugen® for Neovascular Age-Related Macular Degeneration (SUMANA)

NCT00788177 is registered in ClinicalTrials.gov with Klinikum Ludwigshafen as lead sponsor.

NCT NCT00788177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00788177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subretinal Macugen® for Neovascular Age-Related Macular Degeneration (SUMANA)
Lead sponsor
Klinikum Ludwigshafen
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2008
Completion date
December 31, 2012
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration